Global Cord Blood Income Statement

Financials in millions CNY. Fiscal year is April - March.

Millions CNY. Fiscal year is Apr - Mar.

Fiscal Year	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018
Revenue	1,243	1,160	1,221	986.75	936.77
Revenue Growth (YoY)	7.21%	-5.06%	23.79%	5.34%	23.26%
Cost of Revenue	183.31	178.95	189.13	186.03	181.48
Gross Profit	1,060	980.69	1,032	800.73	755.29
Selling, General & Admin	428.79	412.05	452.19	404.38	462.7
Research & Development	22.3	23.77	21.11	14.69	12.72
Operating Expenses	451.08	435.82	473.3	419.07	475.42
Operating Income	608.87	544.87	559.03	381.66	279.86
Interest Expense	-	-	-	-	-3.26
Interest & Investment Income	33.73	32.18	25.87	26.3	22.57
Currency Exchange Gain (Loss)	-0.64	0.16	-0.3	-0.06	0.13
Other Non Operating Income (Expenses)	6.27	8.16	7.39	5.7	4.23
EBT Excluding Unusual Items	648.23	585.37	591.98	413.59	303.54
Gain (Loss) on Sale of Investments	-20.39	25.39	-13.17	-57.13	-
Pretax Income	627.84	610.75	578.81	356.46	303.54
Income Tax Expense	118.35	94.55	101.08	61.26	62.66
Earnings From Continuing Operations	509.48	516.21	477.73	295.2	240.88
Minority Interest in Earnings	-8.42	-7.96	-7.01	-4.08	-3.78
Net Income	501.07	508.25	470.72	291.12	237.1
Net Income to Common	501.07	508.25	470.72	291.12	237.1
Net Income Growth	-1.41%	7.97%	61.69%	22.79%	87.89%
Shares Outstanding (Basic)	122	122	122	121	113
Shares Outstanding (Diluted)	122	122	122	121	119
Shares Change (YoY)	-	-	0.11%	1.75%	63.46%
EPS (Basic)	4.12	4.18	3.87	2.40	2.10
EPS (Diluted)	4.12	4.18	3.87	2.40	1.99
EPS Growth	-1.44%	8.01%	61.25%	20.60%	25.16%
Free Cash Flow	593.82	609.82	599.76	761.43	751.7
Free Cash Flow Per Share	4.88	5.02	4.93	6.27	6.30
Dividend Per Share	-	-	-	-	0.502
Gross Margin	85.26%	84.57%	84.52%	81.15%	80.63%
Operating Margin	48.97%	46.99%	45.77%	38.68%	29.88%
Profit Margin	40.30%	43.83%	38.54%	29.50%	25.31%
Free Cash Flow Margin	47.76%	52.59%	49.10%	77.16%	80.24%
EBITDA	656.79	593.96	608.48	434.02	330.45
EBITDA Margin	52.83%	51.22%	49.82%	43.98%	35.28%
D&A For EBITDA	47.92	49.09	49.45	52.37	50.59
EBIT	608.87	544.87	559.03	381.66	279.86
EBIT Margin	48.97%	46.99%	45.77%	38.68%	29.88%
Effective Tax Rate	18.85%	15.48%	17.46%	17.19%	20.64%
Advertising Expenses	64.92	54.44	49.39	39.59	37.42

Updated Aug 16, 2022. Source: S&P Global Market Intelligence. Standard template. Financial Sources.